相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LncRNA FOXP4-AS1 Promotes Progression of Ewing Sarcoma and Is Associated With Immune Infiltrates
Jiachao Xiong et al.
FRONTIERS IN ONCOLOGY (2021)
Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
Shuzhen Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4
Yu Yang et al.
ONCOTARGETS AND THERAPY (2019)
被撤回的出版物: lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer (Retracted article. See vol. 145, 2022)
Fuquan Jiang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis
Haixia Duan et al.
LIFE SCIENCES (2019)
CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway
Xiaohong Yin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p/VEGF-C pathway in bladder cancer
Peihua Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
LncRNA FTX sponges miR-215 and inhibits phosphorylation of vimentin for promoting colorectal cancer progression
Yi Yang et al.
GENE THERAPY (2018)
Atezolizumab and bladder cancer: facing a complex disease
Carlo Cattrini et al.
LANCET (2018)
Long noncoding RNAs and cancer, an overview
Cristel V. Camacho et al.
STEROIDS (2018)
CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
Xiao-Guang Zhang et al.
CANCER MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
lncRNA DLG1-AS1 Promotes Cell Proliferation by Competitively Binding with miR-107 and Up-Regulating ZHX1 Expression in Cervical Cancer
Xiaohui Rui et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p
Xiaotian Luan et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
Haihai Liang et al.
MOLECULAR CANCER (2018)
LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
Yanxia Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma
Ming Tu et al.
MOLECULAR MEDICINE REPORTS (2017)
被撤回的出版物: Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway (Retracted article. See vol. 35, pg. 345, 2022)
Jintao Wang et al.
CANCER BIOMARKERS (2017)
Long Noncoding RNA and Cancer: A New Paradigm
Arunoday Bhan et al.
CANCER RESEARCH (2017)
A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer
Linda S. Yang et al.
SURGICAL ONCOLOGY-OXFORD (2016)
ceRNA in cancer: possible functions and clinical implications
Xiaolong Qi et al.
JOURNAL OF MEDICAL GENETICS (2015)
miRNA and Cancer; Computational and Experimental Approaches
Yusuf Tutar
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2014)
CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis
Ai-Fang Huang et al.
MOLECULAR CANCER (2013)
Inhibiting CD164 Expression in Colon Cancer Cell Line HCT116 Leads to Reduced Cancer Cell Proliferation, Mobility, and Metastasis in vitro and in vivo
Jingqun Tang et al.
CANCER INVESTIGATION (2012)
The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling
Yi-fang Ping et al.
JOURNAL OF PATHOLOGY (2011)
分享论文
